Kobayashi Hiroshi, Makise Naohiro, Shinozaki-Ushiku Aya, Ishibashi Yuki, Ikegami Masachika, Kohsaka Shinji, Ushiku Tetsuo, Oda Katsutoshi, Miyagawa Kiyoshi, Aburatani Hiroyuki, Mano Hiroyuki, Tanaka Sakae
Department of Orthopaedic Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Case Rep Orthop. 2021 Sep 30;2021:9434222. doi: 10.1155/2021/9434222. eCollection 2021.
Angiomatoid fibrous histiocytoma (AFH) is a rare intermediate malignant tumor that arises mainly in soft tissues, especially in the superficial extremities of patients younger than 30 years. There have been a few reports of AFH arising from sites other than soft tissue, including bone, and unusual site and age make it difficult to diagnose this rare tumor. . Here, we present a case of a 54-year-old man who was examined for chest pain, and computed tomography (CT) incidentally detected a bone tumor at the scapula with destruction of cortical bone and invasion into soft tissue. Magnetic resonance imaging revealed multiple cystic components with fluid-fluid levels. FDG-PET showed uptake at the axillary lymph node. The CT-guided needle biopsy revealed spindle cell sarcoma on histopathology. After neoadjuvant chemotherapy, a scapulectomy was performed. The final postresection histopathological diagnosis was the same as the preoperative diagnosis, and no obvious chemotherapeutic effect was observed. Next-generation sequencing of RNA isolated from paraffin-embedded tumor tissue revealed that these lesions harbored the fusion gene, and the tumor was diagnosed as AFH. C-reactive protein level, which was elevated preoperatively, decreased after the operation, and there was no recurrence or metastasis 5 years after the treatment.
The diagnosis of AFH is difficult when the tumor has an atypical presentation. Comprehensive genomic analysis, especially RNA sequencing, is efficient in diagnosing this rare tumor. Moreover, magnetic resonance imaging findings identical to AFH in soft tissue, the presence of paraneoplastic symptoms such as elevated inflammatory markers, and lymph node swelling were clues towards suspecting this tumor.
血管样纤维组织细胞瘤(AFH)是一种罕见的中间型恶性肿瘤,主要发生于软组织,尤其是30岁以下患者的四肢浅表部位。已有少数关于AFH起源于软组织以外部位(包括骨骼)的报道,非典型的发病部位和年龄使得诊断这种罕见肿瘤变得困难。在此,我们报告一例54岁男性,因胸痛接受检查,计算机断层扫描(CT)偶然发现肩胛骨处有骨肿瘤,伴有皮质骨破坏并侵犯软组织。磁共振成像显示多个含有液-液平面的囊性成分。氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)显示腋窝淋巴结有摄取。CT引导下针吸活检组织病理学显示为梭形细胞肉瘤。新辅助化疗后,进行了肩胛骨切除术。最终切除术后组织病理学诊断与术前诊断相同,未观察到明显的化疗效果。从石蜡包埋的肿瘤组织中分离的RNA进行下一代测序显示,这些病变含有融合基因,该肿瘤被诊断为AFH。术前升高的C反应蛋白水平术后下降,治疗后5年无复发或转移。
当肿瘤表现不典型时,AFH的诊断较为困难。综合基因组分析,尤其是RNA测序,对诊断这种罕见肿瘤很有效。此外,软组织中与AFH相同的磁共振成像表现、炎症标志物升高等副肿瘤症状的出现以及淋巴结肿大是怀疑该肿瘤的线索。